• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性低促性腺激素性性腺功能减退患者开始雄激素治疗后青春期的进展情况。

Progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism.

作者信息

Kulshreshtha Bindu, Khadgawat Rajesh, Gupta Nandita, Ammini Ariachery

机构信息

Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, Delhi, India.

出版信息

Indian J Endocrinol Metab. 2013 Sep;17(5):851-4. doi: 10.4103/2230-8210.117245.

DOI:10.4103/2230-8210.117245
PMID:24083166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3784868/
Abstract

BACKGROUND

Onset of puberty in boys usually occurs by 14 years of age. Some boys may exhibit delayed sexual maturation till about 17-18 years of age. However, pubertal onset beyond 18 years of age is exceedingly rare.

MATERIALS AND METHODS

Patients diagnosed as idiopathic hypogonadotropic hypogonadism (IHH) who had onset of puberty (increase in testicular volume >10 ml) while on androgen therapy were studied. These patients were evaluated prospectively.

RESULTS

There were nine subjects that were included in the study. The pre-therapy testicular volumes ranged from 3 to 6 ml. Luteinizing hormone (LH) levels increased from 1.2 ± 0.96 to 2.8 ± 1.0 IU/L, follicular stimulating hormone (FSH) levels increased from 1.5 ± 0.79 to 3.5 ± 1.9 IU/L, and testosterone increased from 0.36 ± 0.16 to 3.4 ± 2.1 ng/ml. Three out of nine patients had testosterone levels below 3 ng/ml.

CONCLUSION

Our present study indicates that pubertal development can occur in patients presenting with hypogonadotropic hypogonadism after 18 years of age. However, acquired pubertal status may be subnormal.

摘要

背景

男孩青春期通常在14岁时开始。一些男孩的性成熟可能会延迟至17 - 18岁左右。然而,18岁以后出现青春期启动的情况极为罕见。

材料与方法

对诊断为特发性低促性腺激素性性腺功能减退(IHH)且在接受雄激素治疗期间出现青春期启动(睾丸体积增加>10 ml)的患者进行研究。对这些患者进行前瞻性评估。

结果

该研究纳入了9名受试者。治疗前睾丸体积为3至6 ml。促黄体生成素(LH)水平从1.2±0.96 IU/L升至2.8±1.0 IU/L,促卵泡生成素(FSH)水平从1.5±0.79 IU/L升至3.5±1.9 IU/L,睾酮水平从0.36±0.16 ng/ml升至3.4±2.1 ng/ml。9名患者中有3名睾酮水平低于3 ng/ml。

结论

我们目前的研究表明,18岁以后出现低促性腺激素性性腺功能减退的患者可能会发生青春期发育。然而,获得的青春期状态可能未达正常水平。

相似文献

1
Progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism.特发性低促性腺激素性性腺功能减退患者开始雄激素治疗后青春期的进展情况。
Indian J Endocrinol Metab. 2013 Sep;17(5):851-4. doi: 10.4103/2230-8210.117245.
2
Reversal of idiopathic hypogonadotropic hypogonadism.特发性低促性腺激素性性腺功能减退的逆转。
N Engl J Med. 2007 Aug 30;357(9):863-73. doi: 10.1056/NEJMoa066494.
3
The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism.青春期前发育、睾丸成熟的生化标志物以及遗传学在阐明特发性低促性腺激素性性腺功能减退表型异质性中的作用。
J Clin Endocrinol Metab. 2002 Jan;87(1):152-60. doi: 10.1210/jcem.87.1.8131.
4
Role of basal and provocative serum prolactin in differentiating idiopathic hypogonadotropic hypogonadism and constitutional delayed puberty--a diagnostic dilemma.基础和激发性血清催乳素在鉴别特发性低促性腺激素性性腺功能减退和体质性青春期延迟中的作用——诊断困境
J Ayub Med Coll Abbottabad. 2012 Apr-Jun;24(2):73-6.
5
Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty.基础抑制素 B 和抗苗勒管激素检测在诊断青春发育延迟男孩的低促性腺激素性性腺功能减退症(HH)中的作用。
J Clin Endocrinol Metab. 2010 Dec;95(12):5225-32. doi: 10.1210/jc.2010-1535. Epub 2010 Sep 8.
6
Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism.特发性低促性腺激素性性腺功能减退男性长期GnRH治疗结局的预测因素
J Clin Endocrinol Metab. 2002 Sep;87(9):4128-36. doi: 10.1210/jc.2002-020518.
7
Constitutional delayed puberty in males and hypogonadotropic hypogonadism: a reliable and cost-effective approach to differential diagnosis.男性体质性青春期延迟与低促性腺激素性性腺功能减退:一种可靠且经济高效的鉴别诊断方法。
J Pediatr Endocrinol Metab. 2005 Sep;18(9):909-16. doi: 10.1515/jpem.2005.18.9.909.
8
[The status of the gonadotropin releasing hormone test in differential diagnosis of delayed puberty in adolescents over 14 years of age].[促性腺激素释放激素试验在14岁以上青少年青春期延迟鉴别诊断中的地位]
Med Klin (Munich). 1994 Oct 15;89(10):529-33.
9
Pulsatile luteinizing hormone-releasing hormone treatment of male hypogonadotropic hypogonadism.脉冲式促黄体生成激素释放激素治疗男性低促性腺激素性性腺功能减退症。
Fertil Steril. 1988 Sep;50(3):480-6. doi: 10.1016/s0015-0282(16)60137-1.
10
Serum leptin levels in males with delayed puberty during short-term pulsatile GnRH administration.短期脉冲式促性腺激素释放激素给药期间青春期延迟男性的血清瘦素水平。
J Endocrinol Invest. 1999 Jan;22(1):6-11. doi: 10.1007/BF03345471.

引用本文的文献

1
Osteocalcin Levels in Male Idiopathic Hypogonadotropic Hypogonadism: Relationship With the Testosterone Secretion and Metabolic Profiles.男性特发性低促性腺激素性性腺功能减退症患者的骨钙素水平:与睾酮分泌及代谢指标的关系
Front Endocrinol (Lausanne). 2019 Oct 11;10:687. doi: 10.3389/fendo.2019.00687. eCollection 2019.
2
Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment.专家共识文件:先天性低促性腺激素性性腺功能减退症的欧洲共识声明——发病机制、诊断和治疗。
Nat Rev Endocrinol. 2015 Sep;11(9):547-64. doi: 10.1038/nrendo.2015.112. Epub 2015 Jul 21.
3
Central hypogonadotropic hypogonadism: genetic complexity of a complex disease.中枢性性腺功能减退症:一种复杂疾病的遗传复杂性。
Int J Endocrinol. 2014;2014:649154. doi: 10.1155/2014/649154. Epub 2014 Sep 1.
4
Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system.低促性腺激素性性腺功能减退症的逆转和复发:生殖神经内分泌系统的弹性和脆弱性。
J Clin Endocrinol Metab. 2014 Mar;99(3):861-70. doi: 10.1210/jc.2013-2809. Epub 2013 Jan 1.

本文引用的文献

1
Reversal of idiopathic hypogonadotropic hypogonadism.特发性低促性腺激素性性腺功能减退的逆转。
N Engl J Med. 2007 Aug 30;357(9):863-73. doi: 10.1056/NEJMoa066494.
2
Reversible Kallmann syndrome: report of the first case with a KAL1 mutation and literature review.可逆性卡尔曼综合征:首例KAL1基因突变病例报告及文献综述
Eur J Endocrinol. 2007 Mar;156(3):285-90. doi: 10.1530/eje.1.02342.
3
Pubertal androgen therapy in boys.男孩青春期雄激素治疗
Pediatr Endocrinol Rev. 2005 Mar;2(3):383-90.
4
Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene.一个家庭成员中出现的伴有成纤维细胞生长因子受体1基因突变的可逆性卡尔曼综合征、青春期延迟和孤立性嗅觉丧失。
J Clin Endocrinol Metab. 2005 Mar;90(3):1317-22. doi: 10.1210/jc.2004-1361. Epub 2004 Dec 21.
5
Ascertainment and treatment of delayed puberty.青春期延迟的诊断与治疗。
Horm Res. 2003;60 Suppl 3:35-48. doi: 10.1159/000074498.
6
[Puberal FSH deficiency (spermiogenetic infantilism), a special form of partial anterior pituitary gland insufficiency].
Klin Wochenschr. 1959 Jan 15;37(2):105-6. doi: 10.1007/BF01482883.
7
Male hypogonadism. VII. The testis in partial gonadotropic failure during puberty (lack of luteinizing hormone only).
Proc Staff Meet Mayo Clin. 1955 Jan 26;30(2):31-43.
8
The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism.青春期前发育、睾丸成熟的生化标志物以及遗传学在阐明特发性低促性腺激素性性腺功能减退表型异质性中的作用。
J Clin Endocrinol Metab. 2002 Jan;87(1):152-60. doi: 10.1210/jcem.87.1.8131.
9
Management of puberty in constitutional delay of growth and puberty.体质性生长和青春期延迟的青春期管理
J Pediatr Endocrinol Metab. 2001 Jul;14 Suppl 2:953-7. doi: 10.1515/jpem-2001-s207.
10
The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor.
J Clin Endocrinol Metab. 2001 Jun;86(6):2470-5. doi: 10.1210/jcem.86.6.7542.